Are younger COPD patients adequately vaccinated for influenza and pneumococcus?

Gogou, Evdoxia; Hatzoglou, Chrissi; Zarogiannis, Sotirios G.; Siachpazidou, Dimitra; Gerogianni, Irini; Kotsiou, Ourania S.; Varsamas, Charalampos; Gourgoulianis, Konstantinos

doi:10.1016/j.rmed.2022.106988

Cited by 3 publications

(6 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[49] In addition, several studies have shown the effectiveness of vaccinations in lowering the possibility of respiratory illnesses such as bronchitis or pneumonia, as well as flare-ups of COPD. [20,50,51] Nonetheless, their use in these individuals is suboptimal. [52,53] Pulmonary rehabilitation (PR) entails supervised instruction in exercise training, education, and behavioral change to improve physical function and modify behavior.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Perceptions of the effectiveness of non-pharmacological management of respiratory disorders among CRD patients

Aldabayan

2023

Medicine

View full text Add to dashboard Cite

Chronic respiratory diseases (CRDs) are among the leading cause of mortality worldwide. While pharmacological approaches are commonly used to manage symptoms, non-pharmacological management of CRDs is considered crucial in preventing disease progression and improving patient self-efficacy. To describe the perceived effectiveness of non-pharmacological management of CRDs among CRD patients and determine whether the CRD patients perceptions of the effectiveness of non-pharmacological management are associated with their demographic characteristics. An analytic cross-sectional study design was utilized. The non-pharmacological management practices of CRD patients and their perception of the effectiveness of these therapeutic measures were assessed using a researcher-developed questionnaire. Data collection took place in primary healthcare centers in Al Ahsa, Saudi Arabia from October 2021 to March 2022. The proportion of CRD patients who perceived that non-pharmacological interventions were effective was computed. Binary logistic regression was performed to determine the association between the demographic characteristics of the respondents and their perception of the effectiveness of non-pharmacological management. Among the 390 respondents, 42% perceived that non-pharmacological measures were effective. Half of the respondents believed that smoking cessation, influenza vaccination, improving physical activity, and nutrition support helped alleviate CRD symptoms, while less than half of the respondents considered pulmonary rehabilitation, educational programs, and oxygen therapy effective measures to control symptoms. Women were found to be 3.24 times more likely to perceive non-pharmacological interventions as effective (P < .0000) compared to men. Those with university-level education were 66.6% less likely to consider non-pharmacological interventions to be effective (P < .0000) than those who completed preuniversity-level education. Age and marital status did not significantly influence perceptions of effectiveness. Differences in the perceptions of the effectiveness of various non-pharmacological measures to alleviate CRD symptoms existed among the CRD patients of Al Ahsa. The perception of effectiveness was significantly associated with the patient’s gender and educational attainment.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Perceptions of the effectiveness of non-pharmacological management of respiratory disorders among CRD patients

Aldabayan

2023

Medicine

View full text Add to dashboard Cite

show abstract

“…Sequential vaccination of PCV13 and PPSV23 was performed in 12.8% of patients with COPD [ 41 ]. Another group from Greece investigated the pneumococcal vaccination rates in younger COPD patients and found a low coverage of 32.5% in patients aged 40–65 years old [ 42 ]. Positively connected with pneumococcal vaccine coverage was age, advanced stage of COPD, years of COPD diagnosis, respiratory infection within the previous 2 years, comorbidity and smoking cessation [ 42 ].…”

Section: Pneumococcal Vaccinementioning

confidence: 99%

“…Another group from Greece investigated the pneumococcal vaccination rates in younger COPD patients and found a low coverage of 32.5% in patients aged 40–65 years old [ 42 ]. Positively connected with pneumococcal vaccine coverage was age, advanced stage of COPD, years of COPD diagnosis, respiratory infection within the previous 2 years, comorbidity and smoking cessation [ 42 ]. In contrast, gender, education level and marital status did not affect influenza and pneumococcus vaccination rates [ 42 ].…”

Section: Pneumococcal Vaccinementioning

confidence: 99%

“…Positively connected with pneumococcal vaccine coverage was age, advanced stage of COPD, years of COPD diagnosis, respiratory infection within the previous 2 years, comorbidity and smoking cessation [ 42 ]. In contrast, gender, education level and marital status did not affect influenza and pneumococcus vaccination rates [ 42 ]. In a recent study from Turkey, vaccination rates were found to be low (17%) in patients who were frequently hospitalised despite an advanced stage of COPD [ 43 ].…”

Section: Pneumococcal Vaccinementioning

confidence: 99%

See 1 more Smart Citation

The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus

Simon,

Joean,

Welte

et al. 2023

Eur Respir Rev

View full text Add to dashboard Cite

Exacerbations of COPD are associated with worsening of the airflow obstruction, hospitalisation, reduced quality of life, disease progression and death. At least 70% of COPD exacerbations are infectious in origin, with respiratory viruses identified in approximately 30% of cases. Despite long-standing recommendations to vaccinate patients with COPD, vaccination rates remain suboptimal in this population.Streptococcus pneumoniaeis one of the leading morbidity and mortality causes of lower respiratory tract infections. The Food and Drug Administration recently approved pneumococcal conjugate vaccines that showed strong immunogenicity against all 20 included serotypes. Influenza is the second most common virus linked to severe acute exacerbations of COPD. The variable vaccine efficacy across virus subtypes and the impaired immune response are significant drawbacks in the influenza vaccination strategy. High-dose and adjuvant vaccines are new approaches to tackle these problems. Respiratory syncytial virus is another virus known to cause acute exacerbations of COPD. The vaccine candidate RSVPreF3 is the first authorised for the prevention of RSV in adults ≥60 years and might help to reduce acute exacerbations of COPD. The 2023 Global Initiative for Chronic Lung Disease report recommends zoster vaccination to protect against shingles for people with COPD over 50 years.

show abstract

Clinical Management of COPD in the Real World: Can Studies Reveal Errors in Management and Pathways to Improve Patient Care?

Halpin¹

2023

POR

View full text Add to dashboard Cite

Real world data comprise information on health care that is derived from multiple sources outside typical clinical research settings. This review focuses on what real world evidence tells us about problems with the diagnosis of chronic obstructive pulmonary disease (COPD), problems with the initial and follow-up pharmacological and non-pharmacological management, problems with the management of exacerbations and problems with palliative care. Data from real world studies show errors in the management of COPD with delays to diagnosis, lack of confirmation of the diagnosis with spirometry, lack of holistic assessment, lack of attention to smoking cessation, variable adherence to management guidelines, delayed implementation of appropriate interventions, under-recognition of patients at higher risk of adverse outcomes, high hospitalisation rates for exacerbations and poor implementation of palliative care. Understanding that these problems exist and considering how and why they occur is fundamental to developing solutions to improve the diagnosis and management of patients with COPD.

show abstract

Are younger COPD patients adequately vaccinated for influenza and pneumococcus?

Cited by 3 publications

References 42 publications

Perceptions of the effectiveness of non-pharmacological management of respiratory disorders among CRD patients

Perceptions of the effectiveness of non-pharmacological management of respiratory disorders among CRD patients

The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus

Clinical Management of COPD in the Real World: Can Studies Reveal Errors in Management and Pathways to Improve Patient Care?

Contact Info

Product

Resources

About